中国科技核心期刊
CN:31-1600/Q
ISSN:1004-0374
“健康与疾病的免疫”国际学术研讨会通知      关于有网站冒充本刊网站的声明
《生命科学》 2006, 18(1): 41-
RNA干扰及其抗病毒应用的可行性探讨
沈哲旎, 罗志娟*
四川大学华西医学中心基础与法医学院,成都 610041
摘 要: RNA干扰是存在于动植物细胞中的,由双链RNA介导的,序列特异性的mRNA降解过程。在哺乳动物细胞里,RNAi可以由21~25个核苷酸长度的双链小干扰RNA(siRNA)触发。目前,以RNAi为策略来抑制病毒复制的方法已获得了巨大成功。但RNAi具有高度序列特异性,而多种病毒,如HIV-1、HBV A等却具有迅速变异的倾向。本文就病毒进化出的多种逃避RNA干扰的机制以及如何降低病毒对RNAi的耐受力等问题进行了多方面的探讨。
关键词:RNA干扰;基因沉默;siRNA;抗病毒
 
RNA interference and its feasibility in antiviral use
SHEN Zhe-Ni, LUO Zhi-Juan*
Department of Medical Science, West China Center of Medical Sciences, Sichuan University, Chengdu 610041, China
Abstract: RNA interference (RNAi) is the process by which double-stranded RNA(dsRNA) directs sequence-specific degradation of mRNA in animal and plant cells. In mammalian cells, RNAi can be triggered by 21~25 nucleotide duplexes of small interfering RNA (siRNA). Strategies to inhibit virus multiplication based on the siRNAs have gained great accomplishment. But the high sequence specificity of RNA interference, combined with the tendency of the viruses such as HIV-1, HBV A, to rapidly generate sequence variability and their tendency to change their secondary structure or secrete resistant proteins,indicates that these viruses are easy to evolve resistance to RNAi.In this article,the author probe into these problems and bring up some resolvents to these problems.
Key words: RNAi;gene scilencing;siRNA;antivirus
 
首页 | 刊物简介 | 编委会 | 投稿须知 | 广告业务 | 过刊浏览 | 联系我们
中国科学院上海生命科学信息中心《生命科学》编辑部
Copyright © 2012-2015 《生命科学》编辑部 All Rights Reserved.
沪ICP备05033115号-30
您是第2954120 位访问者,欢迎!